Open access · CC-BY
via OpenAlex
Bioenergetic impairment in schizophrenia: role of mitochondrial signaling in synaptic dysfunction - a systematic review
Valerio Ricci, Giovanni Martinotti, Alessio Mosca, Giuseppe Maina
Frontiers in Cell and Developmental Biology · 2026 · ▲ 11 citations
Mitochondrial dysfunction
Altered intercellular communication
Human
Systematic review
Meta-analysis
Review
Abstract
Background: Mitochondrial dysfunction(definition) represents a critical pathophysiological mechanism in schizophrenia, potentially linking bioenergetic impairment to synaptic dysfunction and cognitive deficits. Converging evidence suggests that deficits in oxidative phosphorylation may drive the synaptic pathology contributing to treatment-resistant cognitive and negative symptoms. Objective: To systematically review the evidence linking mitochondrial bioenergetic dysfunction to synaptic impairment in schizophrenia, examining structural, functional, and molecular mechanisms across multiple methodological approaches. Methods: Following PRISMA guidelines, we searched PubMed/MEDLINE, Embase, PsycINFO, and Web of Science from 2000 to 2025 for original research studies investigating mitochondrial function and synaptic dysfunction in schizophrenia. Two independent reviewers screened 2,224 articles, with 29 studies meeting inclusion criteria. Quality was assessed using the Newcastle-Ottawa Scale (median score 7/9). Results: studies revealed reduced complex I (18%-35%) and complex IV activity (22%-28%) in prefrontal cortex, with concurrent synaptic density reductions (27%). Neuroimaging studies demonstrated 20%-22% reductions in ATP synthesis rates correlating with cognitive deficits (r = 0.48) and negative symptoms (r = -0.42). First-episode antipsychotic-naïve patients exhibited comparable bioenergetic abnormalities, indicating primary pathophysiology rather than medication effects. Molecular studies identified impaired calcium homeostasis, oxidative stress (27%-35% glutathione reductions in synaptic compartments), and novel pseudogene regulatory mechanisms perpetuating complex I deficits. Peripheral biomarkers including platelet complex I activity and cell-free mitochondrial DNA showed disease specificity and correlation with cognitive impairment. Substantial methodological heterogeneity precluded meta-analysis but provided complementary evidence across analytical levels. Conclusion: Mitochondrial bioenergetic impairment represents a core, potentially modifiable pathophysiological mechanism driving synaptic dysfunction in schizophrenia. Regional specificity (prefrontal cortex, hippocampus) and cell-type selectivity (pyramidal neurons) provide mechanistic insights into cognitive symptom profiles. Early presence and progressive worsening suggest critical intervention windows. Mitochondrial-targeted therapies merit investigation as novel approaches for treatment-resistant cognitive and negative symptoms.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fcell.2026.1740079
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Ricci, V., Martinotti, G., Mosca, A., & Maina, G. (2026). Bioenergetic impairment in schizophrenia: role of mitochondrial signaling in synaptic dysfunction - a systematic review. <em>Frontiers in Cell and Developmental Biology</em>. https://doi.org/10.3389/fcell.2026.1740079
Vancouver
Ricci V, Martinotti G, Mosca A, Maina G. Bioenergetic impairment in schizophrenia: role of mitochondrial signaling in synaptic dysfunction - a systematic review. Frontiers in Cell and Developmental Biology. 2026. doi:10.3389/fcell.2026.1740079.
BibTeX
@article{valerio2026Bioene,
title = {Bioenergetic impairment in schizophrenia: role of mitochondrial signaling in synaptic dysfunction - a systematic review},
author = {Valerio Ricci and Giovanni Martinotti and Alessio Mosca and Giuseppe Maina},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
doi = {10.3389/fcell.2026.1740079},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Synaptic Neuroscience 2026
Open access · CC-BY
Aging and Alzheimer’s: the critical role of mitochondrial dysfunction and synaptic alterations
Psychiatry International 2026
Open access · CC-BY
Peripheral Inflammatory Biomarkers in First-Episode, Drug-Naïve Major Depressive Disorder: A Systematic Review
International Journal of Molecular Sciences 2021
Open access · CC-BY
Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer’s Disease
Alzheimer's & dementia : the journal of the Alzheimer's Association 2026
Citation only
Biomarker profiles in late-life depression and Alzheimer's disease across and beyond the A/T/N framework: A scoping review.
International Journal of Molecular Sciences 2025
Open access · CC-BY
Mitochondrial Oxidative Phosphorylation System Dysfunction in Schizophrenia
Frontiers in Neuroscience 2020
Open access · CC-BY